SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,170.30 |
Enterprise Value ($M) | 1,119.04 |
Book Value ($M) | 77.28 |
Book Value / Share | 0.91 |
Price / Book | 15.10 |
NCAV ($M) | 32.07 |
NCAV / Share | 0.38 |
Price / NCAV | 36.39 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.61 |
Return on Assets (ROA) | -0.66 |
Return on Equity (ROE) | -1.51 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.42 |
Current Ratio | 4.43 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 185.10 |
Assets | 230.31 |
Liabilities | 153.04 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 14.00 |
Operating Income | -121.29 |
Net Income | -130.39 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -93.42 |
Cash from Investing | -8.44 |
Cash from Financing | 194.66 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Legend Aggregator, LP | 2.20 | -74.10 | |
13G/A | Manning Paul B | 7.90 | 5.54 | |
13G | BlackRock, Inc. | 5.00 | 0.00 | |
13D/A | Caligan Partners LP | 9.80 | 16.06 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
109,800 | 524,353 | 20.94 | |
171,874 | 599,354 | 28.68 | |
131,264 | 586,888 | 22.37 | |
208,629 | 831,832 | 25.08 | |
(click for more detail) |
Similar Companies | |
---|---|
LIXT – Lixte Biotechnology Holdings, Inc. | LPCN – Lipocine Inc. |
LPTX – Leap Therapeutics, Inc. | LSTA – Lisata Therapeutics, Inc. |
LTRN – Lantern Pharma Inc. |
Financial data and stock pages provided by
Fintel.io